New York City, NY -- (SBWIRE) -- 01/23/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: CEL-SCI Corporation (NYSEMKT:CVM), Cobalt International Energy, Inc. (NYSE:CIE), Keryx Biopharmaceuticals (NASDAQ:KERX), Barrick Gold Corporation (USA) (NYSE:ABX)
CEL-SCI Corporation (NYSEMKT:CVM) gained 8.74% recently, while trading on 2.17 million shares, at the price of $1.12. The stock changed hands in a range of $1.07 to $1.17 up till now, bringing its market capitalization at about $62.47 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.53 and was moved to the maximum level of $3.09. CEL-SCI Corporation (CEL-SCI) is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.
Will CVM Continue To Move Higher? Find Out Here
Cobalt International Energy, Inc. (NYSE:CIE) added 4.33% recently, in the current trading session, at $17.55 with a total volume of 1.19 million shares. The stock, on average, trades on a volume of 4.62 million shares. It floated in a range of $17.45 to $17.76 during the recent trading session, with a beta value of 2.28. Its market capitalization now moved to about $7.13 billion. In the past 52 weeks, the share price has not declined below $13.75 or above $30.27. Cobalt International Energy, Inc. independent, oil-focused exploration and production company with a salt prospect inventory in the deepwater of the United States Gulf of Mexico and offshore Angola and Gabon in West Africa. The Company operates its business in two geographic segments: the U.S. Gulf of Mexico and West Africa.
Why Should Investors Buy CIE After The Recent Gain? Just Go Here and Find Out
Keryx Biopharmaceuticals (NASDAQ:KERX) recently recorded a gain of 3.60% and was moving within a range of $14.81-$15.38, its current trading price is $15.12. The stock is moving up till now with a total volume of 2.49 million shares, versus an average volume of 2.65 million shares. The share price hit its 52-week low of $3.20 and $16.18 was the best price. Keryx Biopharmaceuticals, Inc. (Keryx) is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and renal disease. The Company is developing KRX-0401.
What was the Moving Force behind KERX on Bullish Run?Read This Research Report
Barrick Gold Corporation (USA) (NYSE:ABX) added 4.04% in its current trading activity, bringing its market capitalization around $22.75 billion. The share price, after opening at $19.09, hit a high of $19.60 and hovered above $19.08, while its recent trading price was $519.53. The total number of shares changed hands during the current session up till now was 3.63 million shares, as compared to average trading volume of 14.44 million shares. Barrick Gold Corporation (Barrick) is engaged in the production and sale of gold, as well as related activities, such as exploration and mine development. Barrick also produces copper, principally from the Zaldivar and Lumwana mines and holds other interests, including a nickel development project located in Africa.
For How Long ABX will fight for Profitability? Read This Trend Analysis report
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)